Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarials
Author(s) -
Mariëtte van der Watt,
Janette Reader,
Alisje Churchyard,
Sindisiwe H. daba,
Sonja B. Lauterbach,
Jandeli Niemand,
Sijuade Abayomi,
Riëtte van Biljon,
Jessica Connacher,
Roelof van Wyk,
Claire Le Manach,
Tanya Paquet,
Diego Gonzàlez Cabrera,
Christel Brunschwig,
Anjo Theron,
Sonia Lozano-Arias,
Janneth Rodrigues,
Esperanza Herreros,
Didier Leroy,
James Duffy,
Leslie J. Street,
Kelly Chibale,
Dalu Mancama,
Thérèsa L. Coetzer,
LynMarié Birkholtz
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky008
Subject(s) - gametocyte , plasmodium falciparum , biology , in silico , kinase , malaria , phenotypic screening , computational biology , microbiology and biotechnology , biochemistry , phenotype , immunology , gene
Novel chemical tools to eliminate malaria should ideally target both the asexual parasites and transmissible gametocytes. Several imidazopyridazines (IMPs) and 2-aminopyridines (2-APs) have been described as potent antimalarial candidates targeting lipid kinases. However, these have not been extensively explored for stage-specific inhibition of gametocytes in Plasmodium falciparum parasites. Here we provide an in-depth evaluation of the gametocytocidal activity of compounds from these chemotypes and identify novel starting points for dual-acting antimalarials.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom